Isoproterenol-induced hypertrophy may result in distinct left ventricular changes

被引:12
作者
Murad, N [1 ]
Tucci, PJF [1 ]
机构
[1] Univ Fed Sao Paulo, Dept Physiol, Sao Paulo, Brazil
关键词
cardiac hypertrophy; contractile function; isoproterenol; left ventricular distensibility; myocardial mass; relaxation;
D O I
10.1046/j.1440-1681.2000.03254.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. The aim of the present study was to analyse the possible lack of uniformity in isoproterenol (ISO)-induced myocardial hypertrophy. 2. Data obtained for isovolumic hearts isolated from 20 rats treated with ISO (0.3 mg/kg over 8 days) were divided into two groups (H-1, n=10; H-2, n = 10) according to the volume (mean +/- SD) needed to change left ventricle diastolic pressure front 0 to 40 mmHg (H-1, 181 +/- 30 mu L; H-2, 108 +/- 14 mu L). Eight control rats (C; 165 +/- 37 mu L) were used for comparison. 3. In addition to ventricular distensibility differences, the groups differed in terms of myocardial mass (mean +/- SEM: HI, 181 +/- 3 mg > H-2, 166 +/- 3 mg > C, 136 +/- 3 mg; P < 0.001), of relaxation constant (H-2, 43 +/- 4 msec > H-1, 28 +/- 2 msec; P = 0.0012) and of maximum developed circumferential stress (C, 145 +/- 9 kdyn/cm(2) = H-1, 137 +/- 6 kdynlcm' > H-2, 110 +/- 4 kdyn/cm(2); P = 0.002). 4. Our results show that ISO-induced myocardial hypertrophy is not homogeneous. Data obtained for H-2, taken as a whole and compared with H-1 (smaller myocardial mass and impairment of relaxation, elastic stiffness and force generation), suggest that, in some animals, myocardial necrosis and reparative fibrosis may prevail over the stimulus for myocyte growth. The lack of uniformity of ISO-induced myocardial hypertrophy has not been previously reported and may have contributed to the divergence observed in the literature regarding the functional characteristics of the present model.
引用
收藏
页码:352 / 357
页数:6
相关论文
共 26 条
[1]   A calcium stimulated cysteine protease involved in isoproterenol induced cardiac hypertrophy [J].
Arthur, GD ;
Belcastro, AN .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 1997, 176 (1-2) :241-248
[2]   EXERCISE CAPACITY AND CARDIAC-FUNCTION OF RATS WITH DRUG-INDUCED CARDIAC ENLARGEMENT [J].
BALDWIN, KM ;
ERNST, SB ;
MULLIN, WJ ;
SCHRADER, LF ;
HERRICK, RE .
JOURNAL OF APPLIED PHYSIOLOGY, 1982, 52 (03) :591-595
[3]   ISOPROTERENOL-INDUCED MYOCARDIAL FIBROSIS IN RELATION TO MYOCYTE NECROSIS [J].
BENJAMIN, IJ ;
JALIL, JE ;
TAN, LB ;
CHO, K ;
WEBER, KT ;
CLARK, WA .
CIRCULATION RESEARCH, 1989, 65 (03) :657-670
[4]  
BEZNAK M, 1962, CAN J BIOCHEM PHYS, V40, P25
[5]   HEMODYNAMICS DURING CHRONIC STAGE OF MYOCARDIAL DAMAGE CAUSED BY ISOPROTERENOL [J].
BEZNAK, M ;
HACKER, P .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1964, 42 (02) :269-&
[6]  
BING OHL, 1995, J MOL CELL CARDIOL, V27, P283
[7]   CARDIAC INOTROPIC RESPONSES TO CALCIUM AND FORSKOLIN ARE NOT ALTERED BY PROLONGED ISOPROTERENOL INFUSION [J].
BOWLING, N ;
WYSS, VL ;
GENGO, PJ ;
UTTERBACK, B ;
KAUFFMAN, RF ;
HAYES, JS .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 187 (02) :155-164
[8]   FUNCTIONAL-CHANGES IN THE RIGHT AND LEFT-VENTRICLE DURING DEVELOPMENT OF CARDIAC-HYPERTROPHY AND AFTER ITS REGRESSION [J].
CIHAK, R ;
KOLAR, F ;
PELOUCH, V ;
PROCHAZKA, J ;
OSTADAL, B ;
WIDIMSKY, J .
CARDIOVASCULAR RESEARCH, 1992, 26 (09) :845-850
[9]  
HAYES JS, 1986, J PHARMACOL EXP THER, V237, P757
[10]   FIBRILLAR COLLAGEN AND MYOCARDIAL STIFFNESS IN THE INTACT HYPERTROPHIED RAT LEFT-VENTRICLE [J].
JALIL, JE ;
DOERING, CW ;
JANICKI, JS ;
PICK, R ;
SHROFF, SG ;
WEBER, KT .
CIRCULATION RESEARCH, 1989, 64 (06) :1041-1050